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The soluble osteogenic molecular signals of the transforming growth factor-β (TGF-β)
supergene family are the molecular bases of the induction of bone formation and
postnatal bone tissue morphogenesis with translation into clinical contexts. The
mammalian TGF-β3 isoform, a pleiotropic member of the family, controls a vast array of
biological processes including the induction of bone formation. Recombinant hTGF-β3
induces substantial bone formation when implanted with either collagenous bone
matrices or coral-derived macroporous bioreactors in the rectus abdominis muscle
of the non-human primate Papio ursinus. In marked contrast, the three mammalian
TGF-βs do not initiate the induction of bone formation in rodents and lagomorphs.
The induction of bone by hTGF-β3/preloaded bioreactors is orchestrated by inducing
fibrin-fibronectin rings that structurally organize tissue patterning and morphogenesis
within the macroporous spaces. Induced advancing extracellular matrix rings provide the
structural anchorage for hyper chromatic cells, interpreted as differentiating osteoblasts
re-programmed by hTGF-β3 from invadingmyoblastic and/or pericytic differentiated cells.
Runx2 and Osteocalcin expression are significantly up-regulated correlating to multiple
invading cells differentiating into the osteoblastic phenotype. Bioreactors pre-loaded with
recombinant human Noggin (hNoggin), a BMPs antagonist, show down-regulation of
BMP-2 and other profiled osteogenic proteins’ genes resulting in minimal bone formation.
Coral-derived macroporous constructs preloaded with binary applications of hTGF-β3
and hNoggin also show down-regulation of BMP-2 with the induction of limited bone
formation. The induction of bone formation by hTGF-β3 is via the BMPs pathway and it is
thus blocked by hNoggin. Our systematic studies in P. ursinus with translational hTGF-β3
in large cranio-mandibulo-facial defects in humans are now requesting the re-evaluation
of “Bone: formation by autoinduction” in primate models including humans.
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REDUNDANCY AND THE INDUCTION OF
BONE FORMATON BY MULTIPLE
HOMOLOGOUS YET DIFFERENT SOLUBLE
OSTEOGENIC MOLECULAR SIGNALS OF
THE TRANSFORMING GROWTH
FACTOR-β SUPERGENE FAMILY
The osteogenic activity by a series of extracellular matrices,
including the renal parenchyma, was discovered after ligature
of the vascular peduncle in lagomorphs (Sacerdotti and
Frattin, 1901: reviewed by Ripamonti et al., 2006; Ripamonti,
2010). Subsequently, several research laboratories attempted to
isolate and purify the elusive “osteogenic activity” present in
several extracellular matrices, including uroepithelium, bone and
dentine matrices, that was postulated by the classic studies of
Sacerdotti and Frattin (1901), Levander (1945), Moss (1958),
Huggins (1968), Lacroix (1945), Friedenstein (1962), Trueta
(1963), Urist (1965), Sampath and Reddi (1981) and Sampath
et al. (1987). Urist (1965), in his classic contribution to Science,
conclusively showed the bone induction activity of demineralized
bone matrix in rodents and even reported the implantation
of demineralized bone matrix in mandibular defects of human
patients (Urist, 1965).
The definition of the “bone induction principle” and of
the morphogenetic capacity of intact demineralized bone
matrices (Urist, 1965; Urist et al., 1967, 1968; Reddi and
Huggins, 1972) later yielded the isolation of soluble and
insoluble signals by Reddi and co-authors (Sampath and
Reddi, 1981). These classic experiments reported the chaotropic
extraction of the intact demineralized bone matrix into a
soluble signal (the protein extract), and an insoluble signal
or residue, the inactive insoluble collagenous bone matrix
(Sampath and Reddi, 1981, 1983; Reddi, 2000). Implantation
of the lyophilized soluble signal or of the insoluble signal or
substratum did not result in the induction of bone formation,
indicating that the chaotropic dissociative extraction of the
bone matrix disrupted the bone induction cascade of the intact
demineralized bone matrix (Sampath and Reddi, 1981, 1983;
Reddi, 1997).
The reconstitution of the soluble with the insoluble signal
or substratum restored the biological activity of the intact
demineralized bone matrix (Sampath and Reddi, 1981). This
operational reconstitution of a soluble signal with an insoluble
signal or substratum paved the way for the chromatographic
purification of the soluble signals extracted from the intact
demineralized bone matrices (Sampath and Reddi, 1981, 1983;
Sampath et al., 1987; Reddi, 2000). The resolution of the
biological problem of the “bone matrix in the solid state” (Reddi,
1997) facilitated the isolation, purification and molecular cloning
of a novel family of protein initiators, collectively called the
bone morphogenetic proteins (BMPs) (Reddi, 2000; Ripamonti,
2006). The BMPs are endowed with the property of initiating de
novo induction of endochondral bone formation when implanted
in heterotopic extraskeletal sites of a variety of animal models
including primates (Reddi, 2000; Ripamonti, 2006; Ripamonti
et al., 2006).
The BMPs subfamily belongs to the transforming growth
factor-β (TGF-β) supergene family (Wozney et al., 1988;
Kingsley, 1994; Reddi, 2000; Ripamonti, 2006). Approximately
60 members of the TGF-β superfamily have been identified and
can be placed into one of two main subfamilies. Both subfamilies
have a central signaling pathway operating downstream of ligand
binding (Shi and Massagu, 2003). The evolutionary importance
of the TGF-β superfamily is emphasized by the conserved
characteristics of BMP/TGF-β signaling and points to the vital
role that these factors play in vertebrate physiology (Schmierer
and Hill, 2007).
Conserved canonical BMP/TGF-β signaling is comprised of
the BMP/TGF-β ligands which bind cell surface receptors to
relay the signal via the transducers, receptor regulated -Smads
(R-Smads) (Feng and Derynck, 2005). The activated Smads
in turn interact with downstream effector molecules, such as
Runx2 to effect bone differentiation. Non-canonical signaling
(p38 mitogen-activated protein kinase, Smad independent)
also activates Runx2 to activate mesenchymal stem cell
differentiation. The synchronized activity of canonical and non-
canonical signaling is crucial for the formation of bone. An
important feature of BMP/TGF-β regulation in osteogenesis is
the interaction of components of the BMP/TGF-β signaling
pathways with other pathways (Chen et al., 2012). This signaling
cross-talk is responsible for imparting the diversity, flexibility
and intricacies of the BMP/TGF-β pleiotropic functions. The
interaction of TGF-β/BMP signaling with other major pathways,
most notably the Wnt pathway (Issack et al., 2008; Kim et al.,
2013), have been studied in detail. The highly conserved Runx2
transcription factor plays a key role in integrating the signals
from the collaborating pathways (reviewed in Rahman et al.,
2015).
Morphogens of the TGF-β superfamily play pleiotropic roles
in axial patterning, tissue morphogenesis and organogenesis in
both vertebrates and invertebrates (Wozney et al., 1988; Reddi,
2000; Ripamonti et al., 2005; Ripamonti, 2006). The realization
of the pleiotropic activity of the soluble signals of the TGF-β
supergene family has dramatically advanced our molecular and
cellular understandings of tissue induction and morphogenesis
(Reddi, 2000; Ripamonti et al., 2004; Ripamonti, 2006). The
elusive putative osteogenic proteins were finally isolated and
purified to homogeneity from the extracellular matrix of
bone (Ripamonti, 2006). The isolated and later recombinant
molecular signals acted as morphogens, first defined by Turing
as “form generating substances” (Turing, 1952). Morphogens
of the TGF-β supergene family initiate the induction of
bone formation as a recapitulation of embryonic development
(Reddi, 2000; Ripamonti et al., 2000b, 2004; Ripamonti, 2006).
Any perturbations to TGF-β/BMP regulation results in the
pathogenesis of many diseases including those of the human
skeleton, such as fibrodysplasia ossificans progressiva (FOP), a
disabling disease due to mutations of the conserved TGF-β type I
receptor (Kaplan et al., 2009).
Experiments by Sampath et al. (1993) have shown that
the prerogative of the induction of bone formation, so far
solely ascribed to the BMPs family of proteins, could be
extended to additional members of the TGF-β supergene family.
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They reported endochondral osteoinductive activity of human
recombinant decapentaplegic (dpp) and 60A gene products of
the fruit fly Drosophila melanogaster, in the rodent subcutaneous
bioassay (Sampath et al., 1993).
The TGF-β family comprises three mammalian isoforms, the
TGF-β1, -β2, and -β3 proteins. In Homo sapiens each of the
isoforms are encoded by different genes located at different
regions of the genome (Fujii et al., 1986; Barton et al., 1988; ten
Dijke et al., 1988). They are highly homologous with TGF-β1
and TGF-β2 exhibiting 71.4% amino acid homology and TGF-β3
sharing 76% and 80% sequence similarity with TGF-β1 and TGF-
β2, respectively (Marquardt et al., 1987; Yue and Mulder, 2001).
The TGF-β superfamily is considered an ancient protein family
arising approximately 800 million years ago coinciding with
the origin of metazoans. Various components of the signaling
pathways have been detected in the most ancient of the metazoa,
Cnidaria, and sponges (Blitz and Cho, 2009).
Members of the TGF-β superfamily are deeply conserved
and share a high degree of homology, especially in the C-
terminus region (Burt, 1992; Konikoff et al., 2010). The high
levels of amino acid similarity in the ligands, receptors and target
Smads point to a co-evolution predating the common ancestor
of C. elegans, D. melanogaster and Mus musculus (Konikoff
et al., 2010). Members of the TGF-β family share a number of
common structural features. They all have an N-terminal signal
sequence that is removed before the protein is secreted; they
have a large pro-protein region that is also removed prior to
secretion but that assists in the formation of the dimer for the C-
terminal biologically active ligand and they have a ligand domain
approximately 110 amino acids in length that contains a standard
pattern of 6 cysteines (Kahlem and Newfeld, 2009). Many family
members have an additional, seventh, cysteine residue that is
centrally located and involved in the formation of the ligand
dimer.
Phylogenetic analysis relates the distances between branch
points in a phylogenetic tree to evolutionary distance
(Burt, 1992). Using phylogenetics, two large subfamilies
have been identified within the TGF-β superfamily, the
Decapentaplegic/bone morphogenetic protein (Dpp/BMP)
subfamily and the TGF-β/Activin subfamily (Kahlem and
Newfeld, 2009). Dpp from D. melanogaster and BMP-2 and
BMP-4 from M. musculus share 75% homology. In fruit
flies, human BMP-2 and BMP-4 have been shown to rescue
dpp mutant phenotypes. Figure 1 shows a phylogenetic tree
depicting the evolutionary relatedness of the TGF-β isoforms
in the primates, rodents and lagomorphs. The high degree of
conservation within these isoforms is clearly demonstrated and
the tight clustering within the primates shows a high degree of
conservancy between these sequences.
The extension of the unique prerogative of the induction of
bone formation fromBMPs to othermolecularly and functionally
unrelated members of the TGF-β supergene family has indicated
FIGURE 1 | Unrooted dendrogram showing the relationship between the TGF-β1, TGF-β2 and TGF-β3 isoforms. Sequences from Homo sapiens, Pan
troglodytes, Papio anubis, Oryctolagus cuniculus, Mus musculus and Rattus norvegicus were downloaded from GenBank for each of the three TGF-β isoforms.
Sequences were aligned using Clustal X and a phylogenetic tree constructed using the Neighbor-joining algorithm (PHYLogeny Inference Package, version 3.6;
Felsestein, 1995). (A) Overall relationship while (B–D) show each clade in more detail. (GenBank accession numbers: NM_000660; NM_001135599; NM_003239;
XM_009435655; XM_001172158; XM_001161669; XM_009194559; XM_003893100; XM_003902079; XM_008249704; NM_001082660; XM_002719635;
NM_011577; NM_009367; NM_009368; NM_021578; NM_031131; NM_013174).
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the apparent redundancy of gene and gene products initiating
the induction of bone formation in non-human primates
(Ripamonti et al., 1997, 2000a, 2004, 2008a, 2010; Ripamonti,
2006; Ripamonti and Roden, 2010), and by extension, to
human primates (Ripamonti and Ferretti, 2016). Our laboratories
have shown the rapid and substantial induction of bone
formation in full thickness mandibular defects prepared in Papio
ursinus (Ripamonti and Ferretti, 2016). Translational research in
clinical contexts from P. ursinus to severe massive mandibular
discontinuities in selected human patients culminated in the
regeneration of the avulsed body and ramus of the newly formed
mandible, with restoration of the avulsed coronoid process
(Ripamonti and Ferretti, 2016).
Of interest, since our first paper reporting the endochondral
osteoinductivity of the hTGF-β1 isoform (Ripamonti et al.,
1997), no other research laboratories have ever reported any
study on the bone inductive activity of the mammalian TGF-
β isoforms, and the reported human experimentation on bone
tissue engineering by the recombinant hTGF-β3 isoform is
so far the only reported data world-wide (Ripamonti, 2016;
Ripamonti and Ferretti, 2016). There are thus no other studies
to compare with our own published work and our continuous
experimentation to correlate the induction of bone formation by
the hTGF-β3 isoform from the laboratory benches, to P. ursinus
and to H. sapiens in clinical contexts (Ripamonti, 2016).
Experimentation reporting the induction of bone formation
by the hTGF-β3 isoform has shown that the human recombinant
protein is the most powerful inductive morphogen so far
tested in primates (Figure 2; Ripamonti et al., 2008a,b, 2010,
2014, 2015). The Chacma baboon P. ursinus displayed unique
results when compared to rodents, lagomorphs and canines. The
question that thus arose was: why in primates, and in primates
only, are there several related homologous yet molecularly
different morphogens that set into motion the induction of
bone formation? (Figure 2). Until recently, this question still
remained unanswered and needed to be assigned (Klar et al.,
2014; Ripamonti et al., 2014, 2015).
The presence of multiple molecular forms with osteogenic
activity in heterotopic intramuscular sites of primates poses
a major therapeutic challenge in terms of single recombinant
osteogenic protein selection (Ripamonti and Reddi, 1994;
Ripamonti et al., 2004, 2007). The mosaicism of expression of
different BMPs during skeletogenesis and pattern formation has
indicated that different regions of the skeleton including the
craniofacial skeleton may have different ratios of isoforms within
the skeleton, reflecting a therapeutic significance (Ripamonti and
Duneas, 1998; Ripamonti, 2006). The mosaicism of expression
may indicate a site-specific regulatory role of different BMPs
in vivo and underscores the therapeutic importance of site
targeting with exogenous single or binary applications of
specific osteogenic gene products of the TGF-β supergene family
(Ripamonti and Duneas, 1998; Ripamonti, 2006).
In the heterotopic bioassay for bone induction in rodents
(Reddi, 2000), the three mammalian TGF-β isoforms do not
initiate endochondral bone formation. Strikingly, the three
mammalian isoforms, foremost the hTGF-β3 isoform, are
powerful inducers of endochondral bone formation when
implanted in the rectus abdominismuscle of the Chacma baboon
P. ursinuswhen combined with either insoluble collagenous bone
matrices (Figure 2; Ripamonti et al., 2008a) or coral-derived
macroporous bioreactors (Figure 3; Klar et al., 2014; Ripamonti
et al., 2014, 2015).
THE RAPID INDUCTION OF BONE
FORMATON IN PAPIO URSINUS BY THE
RECOMBINANT HUMAN TRANSFORMING
GROWTH FACTOR-β3 ISOFORM
In Papio ursinus, in marked contrast to rodents and lagomorphs,
the hTGF-β3 protein induces large corticalized vascularized
ossicles by day 30 after heterotopic implantation into the rectus
abdominis muscle (Figure 2; Ripamonti et al., 2008a). Of note,
substantial induction of bone formation is also achieved when
the morphogen is combined with coral-derived macroporous
bioreactors (Figure 3).
We undertook a series of experiments to examine the effects
of 250 and 125 µg hTGF-β3 protein on osteoinduction. hTGF-
β3 was added to coral-derived macroporous bioreactors and
implanted into the rectus abdominismuscles of Chacma baboons.
Implants were harvested 60, 30, and 15 days after implantation.
The rectus abdominis striated muscle contains
responding stem cells, distributed in different “niches” in
perivascular/paravascular locations, that contribute a continuous
flow of responding progenitor cells to initiate and enhance the
bone induction cascade (Crisan et al., 2008; Ripamonti et al.,
2008a, 2014; Ripamonti and Roden, 2010). Conclusively, in P.
ursinus the hTGF-β3 protein initiated substantial induction of
bone formation (Figures 2–4; Ripamonti et al., 2008a, 2014,
2015; Klar et al., 2014). Implantation schemes are shown in
Figure 5 (Klar et al., 2013, 2014; Ripamonti et al., 2014, 2015).
When treating coral-derived macroporous bioreactors with
250 µg hTGF-β3 there is prominent induction of bone formation
by day 60 at the very periphery of the implanted constructs, with
limited induction of bone formation within the macroporous
spaces of the heterotopically implanted coral-derived super-
activated bioreactors (Figure 4; Klar et al., 2014; Ripamonti et al.,
2014, 2015).
We hypothesized that TGF-β signaling induces endochondral
bone formation by regulating Noggin expression. Noggin is a
known antagonist of BMPs signaling which inhibits the binding
of selected BMPs to their receptors, thus blocking BMPs activities
and resulting in a substantial decrease of bone formation
(Ripamonti and Roden, 2010; Klar et al., 2014; Ripamonti et al.,
2014, 2015). If the above listed cellular and molecular scenarios
of activation and/or inhibition of BMP/TGF-β family members
are correct, the addition of recombinant human Noggin in
binary application with doses of the hTGF-β3 would inhibit the
osteogenic activity of the expressed and secreted BMPs.We found
that the addition of hNoggin to macroporous bioreactors pre-
loaded with hTGF-β3 limited and/or blocked the bone induction
cascade (Figure 6).
Molecularly, hTGF-β3/treated bioreactors significantly up-
regulated the expression of Runx2 and Osteocalcin (transcription
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FIGURE 2 | Heterotopic induction of bone formation in the rectus abdominis muscle of adult Chacma baboon Papio ursinus by 125 µg of recombinant
human transforming growth factor-β3 (hTGF-β3). hTGF-β3 was reconstituted with allogeneic insoluble collagenous bone matrix as carrier. The operational
reconstitution of the soluble molecular signal, the hTGF-β3, with the collagenous matrix, the insoluble signal, sets into motion the striking osteogenic activity of the
hTGF-β3 isoform, inducing rapid and substantial bone formation. (A,C,E) Series of large corticalized newly formed ossicles 7–9 cm in length in the rectus abdominis
muscle harvested on day 30 generated de novo after intramuscular implantation of 125 µg hTGF-β3. (B,D,F) Undecalcified histological sections cut at 6 µm of the
newly formed large corticalized ossicles after implantation in the rectus abdominis muscle of Papio ursinus and harvested on day 30 (Ripamonti et al., 2008a). (B,D)
Whole mounted undecalcified sections highlighting induction of large corticalized mineralized (dark blue arrows) ossicles harvested on day 30. (F) High power view
detailing the rapid induction of bone formation by a plurality of contiguous plumped osteoblastic cells secreting osteoid matrix (magenta arrow) surfacing newly formed
mineralized bone (dark blue arrow). 6 µm undecalcified sections, stained free-floating with modified Goldner’s trichrome stain.
factors associated with osteoblast differentiation). These
control the differentiation of progenitor stem cells into the
osteoblastic lineage (Klar et al., 2014; Ripamonti et al., 2014).
Morphological analyses on day 15 (Figure 7) showed engineered
microenvironments superactivated by hTGF-β3 reprogramming
the recruitment of differentiated myoblastic and/or pericytic
cells into highly active secreting osteoblasts in the rectus
abdominis striated muscle of P. ursinus. The induction and
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FIGURE 3 | Induction of bone formation by 125 µg recombinant human transforming growth factor-β3 (hTGF-β3). The recombinant morphogen was
reconstituted with coral-derived macroporous bioreactors, implanted in the rectus abdominis muscle of Papio ursinus, and harvested on day 90 after heterotopic
implantation (Ripamonti et al., 2015). (A) Florid induction of bone formation by the hTGF-β3 isoform with trabeculations of newly formed bone (dark blue arrows) across
the macroporous spaces of the coral-derived bioreactor. (B high power view of A, white arrow) Plasticity of the newly formed bone molecularly cross-talking with the
osteogenetic/morphogenetic central blood vessel (light blue arrow) that constructs the spatio/temporal plasticity of the newly formed bone covered by plumped
osteoblastic-like cells (dark blue arrows) enveloping the invading morphogenetic central blood vessel. The plasticity of the two-dimension digital image shown in (B) is
highlighted by the tractional bone movement from the coral-derived bioreactor which is supported by tractional collagenic fibers within the bone matrix (white arrow)
that empower the newly formed bone to form around the central morphogenetic vessel enveloped by the plasticity movements of the newly formed bone as generated
by the hTGF-β3. Thirty micrometer undecalcified sections prepared by using the Exakt cutting and grinding technique, stained with methylene blue basic fuchsin.
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FIGURE 4 | Rapid spatio/temporally regulated tissue induction and morphogenesis by coral-derived macroporous bioreactors. Bioreactors were
pre-loaded with 250 µg recombinant human transforming growth factor-β3 (hTGF-β3). (A,B) Generated tissues were harvested on day 60 after intramuscular rectus
abdominis implantation. Bone is initiated only at the very periphery of the implanted bioreactors (light blue arrows); there is lack of bone formation within the
internal/central areas of the pre-loaded coral-derived constructs (Ripamonti et al., 2015). (C,D) High power views of the newly formed bone at the periphery of the
macroporous constructs showing palisading of plumped osteoblastic-like cells (dark blue arrows) secreting osteoid matrix surfacing mineralized newly formed bone.
(E) Massive induction of heterotopic bone formation by 250µg doses hTGF-β3 extending few centimeters away from the preloaded coral-derived macroporous
construct (light blue arrow) with lack of bone differentiation within the coral-derived macroporous bioreactor. Florid trabeculations of newly formed bone (dark blue
arrows) extending several centimeters away from the coral-derived construct into the adjacent rectus abdominis muscle (dark blue arrows).
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FIGURE 5 | Surgical model and implantation designs. Heterotopic implantation protocols in the rectus abdominis muscle of the Chacma baboon Papio ursinus
for tissue induction and morphogenesis by 7% hydroxyapatite/calcium carbonate coral-derived replicas preloaded with recombinant human transforming growth
factor-β3 (hTGF-β3) with or without 125 or 150µg recombinant human Noggin (hNoggin). Generated constructs were harvested on day 90, 60, and 15 after
intramuscular heterotopic implantation and subjected to molecular and morphological analyses as described (Klar et al., 2014; Ripamonti et al., 2015).
expansion of fibrin-fibronectin extracellular matrix rings
mechanistically predate the induction of a guided extracellular
matrix microenvironment. This provides matrix cues for
differentiating capillaries and sprouting angiogenesis for rapid
cellular differentiation into osteoblastic-like cells secreting bone
matrix, necessary for the induction of bone formation (Figure 7).
Up-regulation of Runx2 and Osteocalcin on day 15 in
hTGF-β3/treated macroporous bioreactors predates rapid
cellular differentiation followed by substantial induction
of bone formation by day 30 (Ripamonti et al., 2014).
By contrast hNoggin/bioreactors down- regulate BMP-2
expression. Down regulation of BMP-2 (critical in bone
development) correlated with minimal bone formation (Klar
et al., 2014; Ripamonti et al., 2014, 2015). Binary applications
of hTGF-β3-hNoggin/bioreactors profoundly inhibited BMP-2
expression on day 15 and 60 but not on day 90 demonstrating
a temporal control of bone differentiation (Klar et al., 2014;
Ripamonti et al., 2014, 2015).
TISSUE PATTERNING AND
MORPHOGENESIS BY THE
TRANSFORMING GROWTH FACTOR-β3
Our systematic experimentation in the non-human primate
P. ursinus has confirmed our hypothesis that the induction of
bone formation as initiated by doses of the hTGF-β3 isoform, is
set into motion by the expression of a variety of BMPs genes. The
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FIGURE 6 | Morphological data mechanistically defining the induction of bone formation by doses of the recombinant human transforming growth
factor-β3. hTGF-β3 was combined with coral-derived macroporous bioreactors and implanted in intramuscular rectus abdominis sites. Generated constructs were
(Continued)
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FIGURE 6 | Continued
harvested on day 90 (Klar et al., 2014; Ripamonti et al., 2015). (A) Induction of bone formation (dark blue arrows) by 125 µg hTGF-β3 pre-loaded onto a macroporous
coral-derived construct. What it is that set into motion the induction of bone formation by the hTGF-β3 isoform in primates? Is it still a bone morphogenetic
proteins-related gene pathway found in primates only or, in primates, the highest phylogenetically evolved species, is it a different and altogether novel molecular
pathway? Differences in gene regulation between primates during development and in response to morphogens may result in differences in sensitivity and
responsiveness to TGF-β superfamily members (Ripamonti and Roden, 2010). Nature relies on common, yet limited molecular mechanisms, tailored to provide the
emergence of specialized tissues and organs (Ripamonti et al., 1997). The bone morphogenetic proteins’ family is indeed an elegant example of Nature’s parsimony in
programming multiple specialized functions deploying molecular isoforms with minor variations in amino acid motifs within highly conserved carboxy-terminal regions
(Ripamonti, 2003, 2006). Macroporous bioreactors with or without the addition of 125 µg hTGF-β3 were additionally pre-loaded with 150 µg hNoggin, a known
antagonist of BMPs signaling which inhibits the binding of selected BMPs to their receptors (for review see Ripamonti et al., 2014). (B,C) The addition of 150 µg
hNoggin profoundly blocks the bone induction cascade by the pre-loaded hTGF-β3 protein. Morphological analyses on day 90 shows limited if any bone formation by
induction (dark blue arrow in B) in macroporous bioreactors pre-treated with binary application hTGF-β3/hNoggin (light blue arrows in C). The use of 125 (Klar et al.,
2014; Ripamonti et al., 2014) or 150 µg hNoggin (Ripamonti et al., 2015) in binary application with 125µg hTGF-β3 has elegantly shown that the complex and
apparently redundant pleiotropic activities of the osteogenic proteins of the TGF-β supergene family (Ripamonti, 2003; Ripamonti et al., 2014) are controlled by the
mammalian TGF-β3 gene, and that the induction of bone formation, as initiated by the hTGF-β3 isoform when implanted in the rectus abdominis muscle of Papio
ursinus, is via the BMPs pathway with hTGF-β3 controlling the induction of bone formation by regulating BMPs expression via Noggin expression (Ripamonti et al.,
2014, 2015). Thirty micrometer undecalcified sections prepared by using the Exakt cutting and grinding technique, stained with methylene blue basic fuchsin.
profiled expressed BMPs result in the secretion of gene products
that initiate the cascade of bone differentiation in the rectus
abdominismuscle of P. ursinus (Ripamonti et al., 2014, 2015).
Critical for the mechanistic understanding of the cascade
of bone formation by pre-treated and untreated macroporous
bioreactors was the harvesting and molecular processing
of the rectus abdominis muscle surrounding the implanted
bioreactors (Ripamonti et al., 2015). Both the adjacent muscle
and the bioreactor tissues were processed for molecular
analyses which were correlated to the induction of bone
formation on decalcified and undecalcified specimens
(Ripamonti et al., 2015). The molecular analyses of the
adjacent surrounding muscle tissues vs. the coral-derived
bioreactor homogenates have helped to mechanistically resolve
the pattern of the induction of bone formation initiated by
the untreated vs. the hTGF-β3/treated macroporous constructs
(Ripamonti et al., 2014, 2015). Furthermore, the molecular
dissection of the adjacent rectus abdominis muscle tissue
has generated additional knowledge on the rapid induction
of bone formation at the periphery of the implanted super-
activated bioreactors by the 250 µg doses of the hTGF-β3
(Ripamonti et al., 2015).
Figure 8 schematically represents the connubium of all the
morphological and molecular experimentation on the initiation
of heterotopic bone formation by hTGF-β3/treated macroporous
bioreactors implanted in the rectus abdominis muscle of
P. ursinus.
Our studies of heterotopic rectus abdominis implantation
have shown that the primary differentiating events that induce
bone formation by untreated macroporous bioreactors develop
within the macroporous spaces. This is associated with lack
of, or minimal BMP-2 gene expression within the surrounding
adjacent muscle (Ripamonti et al., 2015). By contrast, in 250 µg
hTGF-β3/treated bioreactors, both the adjacent muscle and the
macroporous construct show BMP-2 up-regulation (Figure 8),
relating to the temporo/spatial rapid induction of bone formation
at the periphery of the implanted bioreactors (Figures 4, 8). Of
great interest to molecularly dissect the rapid induction of bone
formation by the high doses of hTGF-β3 at the periphery of the
pre-treated macroporous bioreactors, the adjacent muscle tissue
shows the expression of several initiating and morphogenetic
genes including but not limited to BMP-3, BMP-4, BMP-6,
BMP-7, and TGF-β1, TGF-β3 and limited TGF-β2 expression
(Figure 8; Ripamonti et al., 2015).
We conclude that a variety of profiled BMPs and TGF-β
genes, that are expressed at different time points, temporally,
and spatially regulate the induction of bone formation. These
set into motion the bone induction cascade as initiated by the
hTGF-β3 osteogenic device in the primate model (Ripamonti
et al., 2015). In primates, the spatial and temporal expression
of several profiled genes expressed after the implantation
of the recombinant hTGF-β3 isoform controls the complex
multicellular and multigene cascade of the induction of bone
formation (Figure 8).
The data once again challenges the established paradigm
of the induction of bone formation in primates (Ripamonti
et al., 2014, 2015). The rapid and robust induction of bone
formation is initiated by the hTGF-β3 isoformwhen reconstituted
with either insoluble collagenous bone matrices or coral-derived
macroporous bioreactors. This has shown that the hTGF-β3
isoform is a powerful soluble molecular signal that rapidly primes
and induces available progenitor stem cells at a considerable
distance from the implanted bioreactors from the surgically
severed rectus abdominismuscle (Figures 4, 8).
TISSUE TRANSFIGURATION IN VIVO BY
TRANSFORMING GROWTH FACTOR-β
SUPERGENE FAMILY MEMBERS
Of interest, the substantial and robust induction of bone
formation by hTGF-β3 in the non-human primate P. ursinus
has now forced a re-evaluation of the mechanistic insights
of the induction of bone formation in primates, including
humans (Ripamonti et al., 2014, 2015). The hTGF-β3 isoform
does not merely initiate the induction of bone formation but
also sets the molecular and morphological rules of the direct
“tissue transfiguration in vivo” (Ripamonti, 2012, 2015a,b). This
term defines the molecular and morphological evidence of
the induction of bone formation in primate tissues rapidly
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FIGURE 7 | Early tissue induction and morphogenesis by 125 recombinant human transforming growth factor-β3 (hTGF-β3). Doses of hTGF-β3 were
pre-loaded into coral-derived macroporous bioreactors harvested on day 15 after intramuscular rectus abdominis implantation. (A,B) Extracellular matrix induction
and tissue patterning assembling the complex induction of fibrin/fibronectin rings expanding within the invaded macroporous spaces (Klar et al., 2014; Ripamonti
et al., 2014). (A) Differentiation and expansion of fibrin/fibronectin rings (light blue arrows) within the macroporous spaces. (B) Expanding rings (light blue arrows) move
(Continued)
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FIGURE 7 | Continued
by compressing the extracellular matrix ahead of the driving ring. (C) Complex organized extracellular matrix rings provide structural anchorage to differentiating cells
trapped and attached to the highly organized extracellular matrix (dark blue arrows). Aligned cells, interpreted as re-programmed pericytic/paravascular and/or
myoblastic cells into pluripotent stem cells by the hTGF-β3 isoform are deployed for the rapid induction of newly differentiated osteoblastic cells nested and
proliferating within the supportive extracellular matrix substratum (dark blue and light blue arrows). Thirty micrometer undecalcified sections prepared by using the
Exakt cutting and grinding technique, stained with methylene blue basic fuchsin.
FIGURE 8 | Schematic representation of the induction of bone formation by the recombinant human transforming growth factor-β3 (hTGF-β3)
combined with calcium carbonate coral-derived macroporous bioreactors. hTGF-β3/treated coral derived macroporous bioreactors are implanted in the
rectus abdominis muscles of the Chacma baboon Papio ursinus (A) and harvested on day 15, 30 (B), and 60 (C). The rectus abdominis muscle contains responding
mesenchymal stem cells (MSC) (A) that set into motion the bone induction cascade. hTGF-β3/treated bioreactors significantly upregulate Runx2 and Osteocalcin on
day 15 (B). The engineered microenvironment drives the recruitment of differentiated myoblastic and/or pericytic cells into active secreting osteoblasts (B). The
induction and expansion of fibrin/fibronectin extracellular matrix rings (Figure 7) within the macroporous spaces predates the induction of the guided extracellular
micro-environment providing the cues for differentiating capillaries and angiogenesis (B,C). hNoggin treated devices by contrast down- regulate BMP-2 expression
and correlates with minimal bone formation (A). Between day 15 and 30 (B) there is rapid recruitment of osteoblast progenitors with differentiation of osteoblastic-like
cells predominantly at the periphery of the implanted bioreactors with rapid induction of bone formation by day 30–60. Of great interest to note is that with the rapid
induction of bone in treated devices (B), there is the analogous expression of BMP and TGF-βs in the muscle tissue surrounding the macroporous treated devices. On
day 60, in bioreactors treated with 250 µg hTGF-β3, there is a prominent induction of bone at the periphery of the implanted macroporous bioreactors with very limited
bone formation within the macroporous spaces of the treated-bioreactors. The up- regulation of selected morphogenetic genes in the muscular and angiogenic tissues
surrounding the implanted bioreactors is responsible for the rapid and substantial induction of bone formation by day 30 and 60 after implantation with newly formed
bone well beyond the profile of the implanted macroporous constructs (B,C). Terminal bars (T) represent repression; an upward green arrow indicates up- regulation.
transfiguring the striated rectus abdominis muscle into bone
in vivo (Figure 9).
The morphological and molecular evidence of the rapid
transfiguration of muscle tissue into bone by hTGF-β3
(Ripamonti et al., 2008a, 2014, 2015; Klar et al., 2014) is
further potentiated by the synergistic interaction with osteogenic
protein-1 (hOP-1) (Ripamonti et al., 1997; Figure 9). This
has indicated to the Bone Research Laboratory a novel and
unexplored biological function of the hTGF-β3 isoform
(Ripamonti et al., 2016). Injections of hTGF-β3 into malignant
neoplastic primary and secondary masses may induce the rapid
transfiguration of the injected masses into bone to facilitate
tumoral ablation and its surgical debridement (Ripamonti, 2012,
2015a,b). We hypothesize that hTGF-β3 would “osteogenize”
the tumor, transfiguring all available responding cells into
osteoblastic-like cells, possibly altering not only the neoplastic
phenotype but also the neoplastic genotype (Ripamonti, 2012,
2015b), thus controlling differentiation so as to osteogenize
secondary masses.
Lastly, our research does not as yet offer molecular insights
into why the induction of bone formation by the mammalian
hTGF-β proteins occurs in primates only. In previous work,
we have suggested that the above research question should be
a mandatory research goal so as to resolve the induction of
bone formation by the mammalian hTGF-β proteins in primates
(Klar et al., 2014; Ripamonti et al., 2014). We have proposed the
presence of selective molecular redundancy signals amongst the
members of the TGF-β supergene family with a multifactorial
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FIGURE 9 | The rapid biological activity of the recombinant human transforming growth factor-β3 (hTGF-β3). Morphological and molecular re-evaluations
have indicated that the hTGF-β3 isoform “transfigures” mesenchymal tissues/muscle into bone. The synergistic induction of bone formation as engineered by binary
application of recombinant human osteogenic protein-1 (hOP-1) with relatively low doses of hTGF-β1 at the optimal ratio 20:1 (hOP-1: hTGF-β1 or –β3) (Ripamonti
et al., 1997, 2010) has recently introduced the molecular and morphological scenarios of the direct “tissue transfiguration” in vivo, a term that now defines the
molecular and morphological evidence of the rapid induction of bone formation in primate tissue only, rapidly transfiguring the striated rectus abdominis muscle into
bone. (A,B) Transfiguration of the rectus abdominis muscle (white arrows) into bone by the synergistic induction of bone formation by day 15 after heterotopic
implantation. (C) High power view showing the rapid transfiguration of the striated muscle into bone with newly formed mineralized bone (dark blue arrows in C)
surfaced by osteoid seams populated by contiguous osteoblasts (magenta arrows) with muscle fibers (white arrows) possibly degenerating after direct transformation
into bone with osteoid formation (magenta arrows) facing the differentiation of haemopoietic cells and marrow development as early as 15 days after heterotopic
implantation. Six micrometer undecalcified sections stained free-floating with modified Goldner’s trichrome stain.
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tuning of speciation-related molecular evolution in anthropoid
apes at the early Pleistocene boundary (Klar et al., 2014), that
resulted in a tighter control of the bone induction process in
primates species.
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